Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disease Progression and Intervention of Chronic HepatitisB Based on Diabetes and Hyperlipidemia

NCT05057065 is registered in ClinicalTrials.gov with Hong Ren as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05057065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disease Progression and Intervention of Chronic HepatitisB Based on Diabetes and Hyperlipidemia
Lead sponsor
Hong Ren
Phase
Observational
Overall status
Unknown status
Start date
September 15, 2021
Completion date
June 1, 2023
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.